PP_1170x120_10-25-21

Dr. Cara Welch’s appointment as Acting Director of ODSP

CHPA issues statement regarding ODSP leadership

CHPA issues statement regarding ODSP leadership

WASHINGTON — The Consumer Healthcare Products Association (CHPA) issued the following statement regarding the changes in leadership at the FDA Office of Dietary Supplement Programs (ODSP), including Director Steven Tave’s appointment to lead the Office of Regulatory Affairs (ORA) Office of Strategic Planning and Operational Policy, and Dr. Cara Welch’s appointment as Acting Director of